Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look

Rubinstein sold 81,342 shares for approximately $1.21M across multiple transactions from March 6–10, 2026. The sales represented 11.22% of her direct holdings and reduced her direct ownership to 643,471 shares, a routine insider disposition with limited likely market impact.

Analysis

Rubinstein sold 81,342 shares for approximately $1.21M across multiple transactions from March 6–10, 2026. The sales represented 11.22% of her direct holdings and reduced her direct ownership to 643,471 shares, a routine insider disposition with limited likely market impact.